Existing evidence suggests that patients with Alzheimer’s disease who have taken Huperzine A have improved general cognitive function, global clinical status, functional performance and reduced behavioural disturbance compared to patients taking placebos.
Researchers at Rush University Medical Center are testing whether huperzine A, a natural moss extract used in Chinese medicine, can effectively treat the symptoms of Alzheimer's disease.
Scientists at Yale University have developed the first practical method to create a compound called huperzine A in the lab.
The rarest kind of Alzheimer Disease (AD) - the form that transmits from parent to child with a cruel 50 percent likelihood - has been valued for its potential to shed light for the millions of people affected by the common form of AD.
It's on a path full of history and collective memories that more than 500 walkers will gather, on Sunday, May 30th, for the fourth edition of the RONA Walk for Memories. This Alzheimer's disease awareness event, which will take place on the Quays of the Old Port and in the streets of the Old Montreal, aims to raise over $100,000 for the Alzheimer Society of Montreal!
On the eve of World Alzheimer's Day, the Alzheimer Society of Canada has called on the Federal Government to immediately establish a Canadian Alzheimer's disease and dementia partnership to lead and facilitate the development and implementation of a national dementia strategy.
Today the Alzheimer's Drug Discovery Foundation and the Alzheimer's Society (UK) announced a new partnership that will provide funding for research in Alzheimer's disease and related dementias, with the goal of accelerating critical development programs and bringing new treatments to patients. The partnership intends to fund projects up to $1.5 million each focused on drug repurposing, leveraging existing scientific evidence and research to accelerate the drug development process.
Alzheimer's is a progressive form of presenile dementia that is similar to senile dementia except that it usually starts in the 40s or 50s; first symptoms are impaired memory which is followed by impaired thought and speech and finally complete helplessness